Skip to main content
Caplight Logo









DeepScan Diagnostics

DeepScan Diagnostics

Private
HelsinkiHealthcare & Life Scienceshttps://www.deepscandx.com/

Last Round

Seed

Apr 21, 2026

Total Funding Raised

$6.01M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DeepScan Diagnostics is a veterinary biotechnology company that provides diagnostic solutions for veterinarians, enabling early detection of canine cancer and other diseases through advanced CFD® biomarker testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

veterinary diagnosticscanine liquid biopsycfDNA testingcirculating cell-free DNAcfDNAcanine cancer detectiondog cancer testveterinary biotechpet diagnosticsbiomarker testcanine disease monitoringveterinary lab services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepScan Diagnostics Comparables

Compare DeepScan Diagnostics with similar companies based on industry and business-model similarity.

DeepScan Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CanCan Diagnostics
84%
Anivive Lifesciences
77%
VDI Laboratory
74%

DeepScan Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 21, 2026
GrantFeb 3, 2025
Pre SeedNov 25, 2024
GrantFeb 7, 2024

Key People

Founding team and executive leadership

William von der Pahlen

Co-founder, CEO

Founding Team

DeepScan Diagnostics Investors

Notable investors and investment history

DeepScan Diagnostics investors
InvestorRounds
Business FinlandPre Seed, Grant
Calm/Storm VenturesPre Seed, Seed
Runar Bäckström FoundationGrant
Harjavalta GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 40% MoM, reaching 7.1K.

  • Apr 21, 2026

    $4M raised, led by Calm/Storm Ventures

DeepScan Diagnostics Filings

Explore SEC and related filing metadata, where available.

DeepScan Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DeepScan Diagnostics's valuation, stock price, and market status.

Is DeepScan Diagnostics a public or private company?

DeepScan Diagnostics is a private company.

What is the current stock price of DeepScan Diagnostics?

DeepScan Diagnostics is a private company with no public stock price. Caplight tracks DeepScan Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is DeepScan Diagnostics worth (valuation)?

Valuation information for DeepScan Diagnostics is not publicly available.

Can I buy DeepScan Diagnostics stock?

DeepScan Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DeepScan Diagnostics's last funding round?

DeepScan Diagnostics's most recent funding round was Seed on April 21, 2026.

Who are the main investors in DeepScan Diagnostics?

Key investors in DeepScan Diagnostics include Calm/Storm Ventures.

Will DeepScan Diagnostics IPO soon?

No public IPO plans have been announced for DeepScan Diagnostics.

How can I track DeepScan Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepScan Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsinki
Employee Range14
Year Founded2022
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?